Log in to search using one of your social media accounts:

 

Wider sampling of tumor tissues may guide drug choice, improve outcomes
This study challenges current guidelines and supports evaluation of metastatic lesions and circulating tumor DNA. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 15, 2017 Category: Cancer & Oncology Source Type: news

Living With Cancer: Stomach cancer
Stomach cancer: An overview November is Stomach Cancer Awareness Month, which makes it a good time to learn more about this disease. For the past several decades, rates of cancer in the main part of the stomach have been falling worldwide. During the same period, cancer in the area where the top part of the [...] (Source: News from Mayo Clinic)
Source: News from Mayo Clinic - November 10, 2017 Category: Databases & Libraries Source Type: news

How Helicobacter pylori causes gastric cancer
(University of Erlangen-Nuremberg) Gastric cancer is one of the five most fatal types of cancer. According to the statistics of the World Health Organization about 750,000 patients die each year after developing the disease. The main cause is thought to be the bacterium Helicobacter pylori. Researchers at Friedrich-Alexander-Universit ä t Erlangen-N ü rnberg (FAU) have now identified two mechanisms through which this bacterium can cause gastric cancer. Their findings could result in the development of new therapeutic approaches. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 7, 2017 Category: Cancer & Oncology Source Type: news

Stomach Cancer Gastric Cancer in Children
Stomach Cancer (Gastric Cancer) in Children (Source: eMedicineHealth.com)
Source: eMedicineHealth.com - November 6, 2017 Category: General Medicine Source Type: news

Surgery Boosts Gastric Cancer Survival After Noncurative Endoscopic Resection Surgery Boosts Gastric Cancer Survival After Noncurative Endoscopic Resection
Additional surgery after noncurative endoscopic submucosal dissection (ESD) for early gastric cancer is associated with improved survival, according to a study from Korea.Reuters Health Information (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - November 3, 2017 Category: Surgery Tags: Hematology-Oncology News Source Type: news

Having a curved penis brings a higher risk of cancer
A study of 1.5million men by Baylor College in Houston, Texas, found that a curved penis causes a higher risk of testicular cancer by 40%, melanoma by 29% and stomach cancer by 40%. (Source: the Mail online | Health)
Source: the Mail online | Health - November 2, 2017 Category: Consumer Health News Source Type: news

Does your (or your partner's) penis look like THIS? You could be at risk of CANCER
MEN with a bent penis could be at higher risk of developing stomach and testicular cancer, scientists have revealed. (Source: Daily Express - Health)
Source: Daily Express - Health - November 2, 2017 Category: Consumer Health News Source Type: news

Shifting bacterial communities in the stomach may influence cancer risk
(PLOS) Different changes to the microbial community of the stomach may explain why related conditions are associated with different risk levels and types of gastric tumor, according to a new study in PLOS Pathogens. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - November 2, 2017 Category: Cancer & Oncology Source Type: news

Popular Over-The-Counter Antacids Could Increase The Risk Of Stomach Cancer
This study was not able to prove that the medications lead to a higher risk of gastric cancer, it just suggested an association. They also studied conflicts with another recent study that suggested no increased risk of stomach cancer with these medications. That said, doctors and patients should exercise caution when using them over a long period of time.   (Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire)
Source: WBZ-TV - Breaking News, Weather and Sports for Boston, Worcester and New Hampshire - November 1, 2017 Category: Consumer Health News Authors: Health – CBS Boston Tags: Health Healthwatch Local News Seen On WBZ-TV Syndicated Local Dr. Mallika Marshall Source Type: news

Acid reflux drugs could double your risk of stomach cancer
Researchers from the University of Hong Kong and University College London found that acid reflux medications, such as Prilosec, could double your risk of developing stomach cancer. (Source: the Mail online | Health)
Source: the Mail online | Health - November 1, 2017 Category: Consumer Health News Source Type: news

Cancer Risk Elevated in Men With Peyronie's Disease Cancer Risk Elevated in Men With Peyronie's Disease
Men with Peyronie's disease (PD) are at increased risk of malignancy including cancer of the stomach and testis, suggesting they may need additional surveillance after diagnosis and treatment for PD, say researchers from Baylor College of Medicine in Houston.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 1, 2017 Category: Consumer Health News Tags: Urology News Source Type: news

Long-term PPI use linked to doubled risk for stomach cancer: Study
A study at University College London and the University of Hong Kong suggests long-term use of PPIs for acid reflux may double the risk for stomach cancer. (Source: Health News - UPI.com)
Source: Health News - UPI.com - November 1, 2017 Category: Consumer Health News Source Type: news

Acid reflux drugs linked to increased stomach cancer risk
Conclusion PPIs are commonly used medicines for acid reflux. This may seem like alarming news for the many people in the UK who take them, but it's important to remember that the overall risk of stomach cancer is still very low. This study has several limitations that mean we should be cautious about the results: This type of study can't prove PPIs caused the increased risk of cancer. The increased risk could be down to other factors. Researchers were unable to adjust their figures to take account of some relevant confounding factors, such as alcohol and tobacco use, as these weren't routinely recorded. Almost all the pati...
Source: NHS News Feed - November 1, 2017 Category: Consumer Health News Tags: Cancer Source Type: news

Long-term PPI use linked to doubling in stomach cancer risk
The long-term use of proton pump inhibitors, commonly used to treat acid reflux, is linked to a more than doubling in the risk of developing stomach cancer, according to researchers. (Source: Nursing Times)
Source: Nursing Times - November 1, 2017 Category: Nursing Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
Popping certain heartburn drugs like they're candy might up your odds for stomach cancer, new research suggests. (Source: WebMD Health)
Source: WebMD Health - November 1, 2017 Category: Consumer Health News Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
Source: HealthDay Related MedlinePlus Pages: Heartburn, Stomach Cancer (Source: MedlinePlus Health News)
Source: MedlinePlus Health News - November 1, 2017 Category: Consumer Health News Source Type: news

Medical News Today: Common acid reflux drug increases stomach cancer risk
Proton pump inhibitors are used to treat acid reflux. A study finds that if they are taken regularly over the long-term, they increase stomach cancer risk. (Source: Health News from Medical News Today)
Source: Health News from Medical News Today - November 1, 2017 Category: Consumer Health News Tags: GastroIntestinal / Gastroenterology Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
Title: Are Some Heartburn Meds Tied to Stomach Cancer?Category: Health NewsCreated: 11/1/2017 12:00:00 AMLast Editorial Review: 11/1/2017 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - November 1, 2017 Category: Cancer & Oncology Source Type: news

PPI Use After H. pylori Eradication Therapy Tied to Increased Risk for Gastric Cancer (FREE)
By Amy Orciari Herman Edited by David G. Fairchild, MD, MPH, and Lorenzo Di Francesco, MD, FACP, FHM Long-term use of proton-pump inhibitors (PPIs) after treatment for Helicobacter pylori infection is associated with increased risk for gastric cancer, according to a … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - November 1, 2017 Category: Primary Care Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - November 1, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Oncology, Pharmacy, News, Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
(Source: Cancercompass News: Other Cancer)
Source: Cancercompass News: Other Cancer - November 1, 2017 Category: Cancer & Oncology Source Type: news

Long-term use of PPIs linked to doubling in stomach cancer risk
Risk rose with dose and duration of treatment after H pylori eradication Related items fromOnMedica Proton pump inhibitors associated with raised mortality Oesophageal and stomach cancer linked to early adulthood overweight Experts link alcohol to stomach cancer (Source: OnMedica Latest News)
Source: OnMedica Latest News - November 1, 2017 Category: UK Health Source Type: news

Heartburn Drugs Tied to Stomach Cancer Risk
After treatment for H. pylori infection, people who took proton pump inhibitors were at increased risk of stomach cancer. (Source: NYT Health)
Source: NYT Health - October 31, 2017 Category: Consumer Health News Authors: NICHOLAS BAKALAR Tags: Stomach Cancer Ulcers Heartburn Bacteria Helicobacter Pylori (Bacterium) Source Type: news

Acid reflux drug linked to more than doubled risk of stomach cancer – study
There are more than 50m prescriptions for proton pump inhibitors in the UK, though they have previously been linked to side-effects and increased risk of deathA drug commonly used to treat acid reflux is linked to a more than doubled risk of developing stomach cancer, researchers have claimed.Proton pump inhibitors (PPIs) reduce the amount of acid made by the stomach and are used to treat acid reflux and stomach ulcers.Continue reading... (Source: Guardian Unlimited Science)
Source: Guardian Unlimited Science - October 31, 2017 Category: Science Authors: Press Association Tags: Drugs Cancer Health Society Science Source Type: news

Stomach cancer warning: Taking long-term acid reflux medication could DOUBLE your risk
STOMACH cancer is one of the most common cancers in the UK. But taking particular medication to treat acid reflux - or heartburn - could double your risk. (Source: Daily Express - Health)
Source: Daily Express - Health - October 31, 2017 Category: Consumer Health News Source Type: news

Gastric Cancer Risk Doubled With Long-term PPI Use Gastric Cancer Risk Doubled With Long-term PPI Use
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Long-term PPI Use Tied to Doubled Risk for Gastric Cancer Long-term PPI Use Tied to Doubled Risk for Gastric Cancer
The risk for gastric cancer increases with the dose and duration of proton-pump inhibitor use after successful H pylori eradication.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - October 31, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Are Some Heartburn Meds Tied to Stomach Cancer?
TUESDAY, Oct. 31, 2017 -- Popping certain heartburn drugs like they're candy might up your odds for stomach cancer, new research suggests. The risk was proportionate to how long and how often these drugs, called proton pump inhibitors (PPIs), were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - October 31, 2017 Category: General Medicine Source Type: news

Bacteria eradication reduces gastric cancer risk by 22 percent in over-60s, new research shows
(Spink Health) The research analyzed the risk of gastric cancer development in a large group of individuals who had received antibiotic therapy to treat H. pylori infection. Of those who had been treated over the age of 60, 0.8 percent developed gastric cancer, in comparison to 1.1 percent of patients in an age-matched general population sample. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Long-term aspirin use reduces the incidence of digestive cancers by up to 47 percent
(Spink Health) In a study involving over 600,000 people, those prescribed with aspirin showed a 47 percent reduction in liver and esophageal cancer incidence, a 38 percent reduction in gastric cancer incidence, a 34 percent reduction in pancreatic cancer incidence and a 24 percent reduction in colorectal cancer incidence. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - October 30, 2017 Category: Cancer & Oncology Source Type: news

Gastric Cancer Incidence Down, Survival Up
Incidence declined between 1984 and 2014, but long - term survival rates are still low (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - October 27, 2017 Category: Cancer & Oncology Tags: Gastroenterology, Internal Medicine, Oncology, Pathology, Journal, Source Type: news

BIOCAD enters the European market
The largest Russian biotechnology company BIOCAD plans to enter the European market with oncological and autoimmune medicines. So far, there are seven molecules in the European portfolio of BIOCAD. This are innovative and biosimilar products, which could be used in treatment of melanoma, breast, stomach, kidney and lung cancer, rheumatoid arthritis, psoriasis and multiple sclerosis. (Source: World Pharma News)
Source: World Pharma News - October 25, 2017 Category: Pharmaceuticals Tags: Featured Business Business and Industry Source Type: news

Helicobacter pylori: Dodging the bullet
(Ludwig-Maximilians-Universit ä t M ü nchen) Helicobacter pylori is a widespread bacterial pathogen that infects the lining of the stomach, where it can cause ulcers and even cancer. As a new study shows, its genetic variability complicates efforts to develop an effective vaccine. (Source: EurekAlert! - Biology)
Source: EurekAlert! - Biology - October 25, 2017 Category: Biology Source Type: news

Patients create Canada’s first stomach cancer support group
(Source: St. Michael's Hospital News and Media)
Source: St. Michael's Hospital News and Media - October 24, 2017 Category: Hospital Management Tags: Hospital News Source Type: news

Weight Loss in Italy?
One of the women I work with wanted to know about the new diet drug called Belviq. The FDA is always approving a new “miracle” weight-loss pill, only to recall it a few years later. To date, at least 34 diet drugs have been taken off the market. Diet pills cause all kinds of problems — heart attack, stroke and psychiatric disorders. And Belviq isn’t any different. Some of its side effects include suicidal thoughts, a racing heartbeat, hallucinations and more… The European Union banned Belviq. The reason? It causes cancer in animals.  And here’s the real irony… Clinical tri...
Source: Al Sears, MD Natural Remedies - October 19, 2017 Category: Complementary Medicine Authors: Cathy Card Tags: Anti-Aging Source Type: news

RBC analysts say Athenex could achieve 'blockbuster sales in breast and gastric cancer'
The lofty view from a respected industry analyst, who give Athenex shares a $35 price target. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - October 17, 2017 Category: Pharmaceuticals Authors: Dan Miner Source Type: news

Searching for a Doctor at 3,000 Metres High
Celestina of Porcón Alto, a rural region high in the Andes, whose family has lived on the same plot of land for generations. Credit: Andrea Vale/IPSBy Andrea ValePORCÓN, Peru, Oct 6 2017 (IPS)Good healthcare can be hard to get – particularly when one lives on top of a mountain. The road to Porcón in the Cajamarca region of Peru, therefore, is as breathtaking as it is sobering. With every step further into its isolated natural beauty, a group of volunteers sent to deliver healthcare essentials are reminded how long the trek would be in an emergency.After a bus has taken the volunteers as far as it...
Source: IPS Inter Press Service - Health - October 6, 2017 Category: International Medicine & Public Health Authors: Andrea Vale Tags: Development & Aid Featured Headlines Health Inequity Latin America & the Caribbean Population Poverty & SDGs Women's Health Andes diabetes Malnutrition obesity Peru underweight Source Type: news

Mesothelioma Doctor Creates Preoperative Drink for Patients
Peritoneal mesothelioma specialist Dr. Charles Conway wants to make major surgery an easier, more manageable experience for his patients. His latest innovation — a preoperative, complex-carbohydrate beverage — should help considerably. Conway, director of surgical oncology at the Ridley-Tree Cancer Center in Santa Barbara, California, will begin offering patients the novel drink customized to speed recovery and lessen the risk of dangerous side effects. Conway designed SurgiStrong RecoverAid, a uniquely blended product to fill a void in the growing Enhanced Recovery After Surgery (ERAS) programs that have sprun...
Source: Asbestos and Mesothelioma News - September 29, 2017 Category: Environmental Health Authors: Matt Mauney Tags: citrulline Dr. Charles Conway mesothelioma surgery recovery mesothelioma surgery side effects Ochsner Cancer Center peritoneal mesothelioma preoperative complex-carbohydrate beverage Ridley-Tree Cancer Center Santa Barbara surgery-induce Source Type: news

Backed by Yale Cancer Center research, FDA approves new stomach cancer drug
A drug whose clinical testing was led by Dr. Charles Fuchs has become the first immunotherapy treatment for advanced stomach cancer. (Source: Yale Science and Health News)
Source: Yale Science and Health News - September 25, 2017 Category: Universities & Medical Training Source Type: news

Merck ’s Keytruda receives accelerated FDA approval for GEJ adenocarcinoma
Merck ’s Keytruda (pembrolizumab) has received approval from the US Food and Drug Administration (FDA) to treat patients with recurrent locally advanced or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - September 24, 2017 Category: Pharmaceuticals Source Type: news

First Immunotherapy Approved for Gastric Cancer First Immunotherapy Approved for Gastric Cancer
Pembrolizumab is now indicated for third-line treatment of gastric or gastroesophageal junction cancer.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - September 23, 2017 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

How the Graham-Cassidy Proposal Would Hurt Communities of Color
The repeated efforts by Congress to repeal the Affordable Care Act (ACA) can feel endless — legislators keep reviving our deepest fears about how to keep our loved ones and ourselves healthy. Even though repeal was defeated in the Senate just a few months ago, there is a new bill that is as bad as, if not worse than, the previous version. Key Senators are ramming the legislation — known as Graham-Cassidy — through the chamber at warp speed. As two people who worked to make Obamacare a reality, we don’t like what we see. There will be devastating consequences for tens of millions of Americans &mdash...
Source: TIME.com: Top Science and Health Stories - September 22, 2017 Category: Consumer Health News Authors: Chris Lu, Kathy Ko Chin Tags: Uncategorized Health Care Source Type: news

FDA Approves Merck ’s Keytruda (pembrolizumab) for Previously Treated Patients with Recurrent Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Cancer Whose Tumors Express PD-L1
KENILWORTH, N.J.--(BUSINESS WIRE) September 22, 2017 --Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration (FDA) has approved Keytruda (pembrolizumab), the company ’s... (Source: Drugs.com - New Drug Approvals)
Source: Drugs.com - New Drug Approvals - September 22, 2017 Category: Drugs & Pharmacology Source Type: news

Stomach cancer breakthrough on horizon: Cell investigation could lead to new treatment
STOMACH cancer and gastrointestinal cancer cures could be on the horizon after a scientist pledged to investigate how the disease disrupts the growth of healthy cells. (Source: Daily Express - Health)
Source: Daily Express - Health - September 11, 2017 Category: Consumer Health News Source Type: news

Pembrolizumab: promising response rate in pretreated metastatic gastric cancer
(European Society for Medical Oncology) Pembrolizumab has shown a promising response rate in patients with pretreated metastatic gastric cancer, according to late-breaking results from the KEYNOTE-059 trial presented today at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

New data confirms superiority of docetaxel based triplet therapy in gastric cancer
(European Society for Medical Oncology) The superiority of docetaxel based triplet therapy over standard care in patients with resectable esophago-gastric cancer has been confirmed in late-breaking results from the FLOT4 trial presented at the ESMO 2017 Congress in Madrid. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - September 8, 2017 Category: International Medicine & Public Health Source Type: news

Consider plant-based diet for treating reflux symptoms
PPIs no better than plant-based Mediterranean diet plus alkaline water at improving LPR symptoms, research suggests Related items fromOnMedica Oesophageal and stomach cancer linked to early adulthood overweight Plant protein consumption linked to increased longevity Plant-based diet not always best for heart health (Source: OnMedica Latest News)
Source: OnMedica Latest News - September 8, 2017 Category: UK Health Source Type: news

Personalized Cancer Vaccine Company Raises $93 Million
Venture funds seeded by drug giant Eli Lilly and search behemoth Alphabet are giving $92.7 million to a startup that aims to use machine learning to create personalized treatments for lung and stomach cancer. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - September 7, 2017 Category: Pharmaceuticals Authors: Matthew Herper, Forbes Staff Tags: NYSE:LLY NASDAQ:GOOG Source Type: news

What is a stoma? Woman fitted with colostomy bag after bowel cancer surgery explains
A STOMA is where a section of the bowel is brought out through an opening in the stomach area - and bowel movements are collected in a pouch attached the the skin. (Source: Daily Express - Health)
Source: Daily Express - Health - September 2, 2017 Category: Consumer Health News Source Type: news